Skip to content

The expression of growth differentiation factor 15 in gallbladder carcinoma

The expression of growth differentiation factor 15 in gallbladder carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038309
Enrollment
Unknown
Registered
2020-09-17
Start date
2017-01-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallbladder carcinoma

Interventions

patients with gallbladder cancer group:Nil
Control group:Nil

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with primary gallbladder cancer, and all of them had not received radiotherapy, chemotherapy or immunotherapy before surgery; 2. All patients with gallbladder cancer underwent radical resection of gallbladder cancer; 3. In the control group, patients with chronic cholecystitis and healthy volunteers who were treated at the same time as patients with gallbladder cancer were randomly selected, and none of them had other basic diseases.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
GDF-15;

Countries

China

Contacts

Public ContactHongshan Liu

He'nan Provincial People's Hospital

liuhongshan@163.com+86 13838129692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026